Ann G Schwartz Selected Research

Drug Therapy (Chemotherapy)

11/2021	Chemotherapy-induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes.
10/2021	Chemotherapy-Induced Peripheral Neuropathy: Mechanisms and Therapeutic Avenues.
4/2019	Identification and Characterization of Synthetic Viability with ERCC1 Deficiency in Response to Interstrand Crosslinks in Lung Cancer.
1/2019	Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population.
1/2016	Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.
1/2016	Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival.
5/2015	CHRNA5 risk variant predicts delayed smoking cessation and earlier lung cancer diagnosis--a meta-analysis.
6/2009	Patterns of care in a population-based sample of soft tissue sarcoma patients in the United States.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ann G Schwartz Research Topics

Disease

43	Neoplasms (Cancer) 12/2021 - 01/2003
33	Lung Neoplasms (Lung Cancer) 01/2022 - 04/2005
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 12/2007
9	Ovarian Neoplasms (Ovarian Cancer) 12/2019 - 09/2014
7	Breast Neoplasms (Breast Cancer) 05/2020 - 01/2003
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 09/2008
5	Ovarian Epithelial Carcinoma 01/2019 - 03/2016
5	Adenocarcinoma of Lung 12/2015 - 08/2003
3	Peripheral Nervous System Diseases (PNS Diseases) 11/2021 - 01/2019
3	Inflammation (Inflammations) 01/2019 - 03/2007
3	Adenocarcinoma 12/2015 - 04/2005
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 10/2014
1	Obesity 12/2021
1	Painful Neuropathy 10/2021
1	Hypertension (High Blood Pressure) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Endometriosis 01/2018
1	Vitamin D Deficiency 10/2016
1	Arthritis (Polyarthritis) 03/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2016
1	Mesothelioma 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2014
1	Tobacco Use Disorder (Nicotine Dependence) 12/2013
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2012

Drug/Important Bio-Agent (IBA)

12	SmokeIBA 10/2020 - 04/2005
9	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2004
8	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2003
8	Hormones (Hormone)IBA 01/2020 - 12/2007
7	Biological ProductsIBA 12/2021 - 09/2009
6	Estrogens (Estrogen)FDA Link 07/2015 - 10/2005
4	ORALIT (ORS)IBA 01/2018 - 10/2006
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 09/2009
4	Tobacco Smoke Pollution (Passive Smoking)IBA 10/2017 - 12/2007
3	Interleukin-10 (Interleukin 10)IBA 01/2019 - 06/2009
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 06/2009
3	AsbestosIBA 01/2016 - 09/2008
3	Progestins (Progestagens)IBA 07/2015 - 10/2009
3	ParaffinIBA 05/2013 - 10/2005
3	Tyrosine Kinase InhibitorsIBA 03/2011 - 05/2007
2	Indicators and Reagents (Reagents)IBA 12/2021 - 01/2008
2	Estrogen ReceptorsIBA 05/2020 - 12/2007
2	A-Form DNA (A-DNA)IBA 04/2019 - 01/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 06/2009
2	Interleukin-15 (Interleukin 15)IBA 01/2019 - 06/2009
2	Vitamin D FDA LinkGeneric 01/2019 - 10/2016
2	Interleukin-8 (Interleukin 8)IBA 01/2019 - 03/2016
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2016 - 01/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2016 - 01/2008
2	CytokinesIBA 03/2016 - 06/2009
2	P-2 (P 2)IBA 01/2016 - 02/2010
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2013 - 11/2012
2	Formaldehyde (Formol)FDA Link 05/2013 - 01/2011
2	MethyltransferasesIBA 06/2012 - 08/2003
2	CarcinogensIBA 05/2012 - 09/2009
2	Contraceptive Agents (Contraceptives)IBA 06/2006 - 02/2005
1	adenovirus receptorIBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	DiureticsIBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	EndonucleasesIBA 04/2019
1	PlatinumIBA 04/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Platinum Compounds (Compounds, Platinum)IBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	InterferonsIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Chemokine CCL3IBA 01/2019
1	Monocyte Chemoattractant ProteinsIBA 01/2019
1	taxaneIBA 01/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	AntioxidantsIBA 01/2017
1	SeleniumIBA 01/2017
1	CalciumIBA 10/2016
1	Lactose FDA LinkGeneric 10/2016
1	PowdersIBA 10/2016
1	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2016
1	Analgesics (Analgesic Drugs)IBA 03/2016
1	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 02/2016
1	CarbohydratesIBA 02/2016
1	SugarsIBA 02/2016
1	Oral ContraceptivesIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 12/2014
1	Untranslated Regions (Untranslated Region)IBA 12/2014
1	3' Untranslated Regions (3' UTR)IBA 12/2014
1	LigandsIBA 09/2014
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 09/2014
1	Progesterone FDA LinkGeneric 03/2014
1	CotinineIBA 12/2013
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2013
1	Glutathione Transferase (Glutathione S-Transferase)IBA 06/2012

Therapy/Procedure

18	Therapeutics 01/2021 - 06/2009
8	Drug Therapy (Chemotherapy) 11/2021 - 06/2009
2	Immunotherapy 12/2018 - 11/2017
2	Hysterectomy 07/2017 - 12/2004
1	Continuity of Patient Care 12/2019
1	Aftercare (After-Treatment) 01/2018
1	Tubal Sterilization (Tubal Ligation) 10/2017
1	Combined Modality Therapy 01/2016
1	Lasers (Laser) 02/2015